Almeda Ventures Limited Partnership (TLV:AMDA)
244.00
+5.60 (2.35%)
At close: May 20, 2026
TLV:AMDA Market Cap
TLV:AMDA has a market cap or net worth of 47.33 million as of May 20, 2026. Its market cap has increased by 82.19% in one year.
Market Cap
47.33M
Enterprise Value
33.30M
Revenue
7.86M
Ranking
n/a
PE Ratio
7.65
Stock Price
244.00
Market Cap Chart
Since October 7, 2020, TLV:AMDA's market cap has decreased from 53.94M to 47.33M, a decrease of -12.27%. That is a compound annual growth rate of -2.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 47.33M | 30.69% |
| Dec 30, 2025 | 36.21M | 39.40% |
| Dec 25, 2024 | 25.98M | 2.44% |
| Dec 31, 2023 | 25.36M | 55.32% |
| Dec 29, 2022 | 16.33M | -70.81% |
| Dec 30, 2021 | 55.94M | 14.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 7, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 116.55B |
| Danel (Adir Yeoshua) | 2.62B |
| Amal Holdings A.D. | 2.40B |
| BrainsWay | 1.85B |
| Nissan Medical Industries | 70.57M |
| Clal Biotechnology Industries | 50.98M |
| Together Pharma | 45.61M |
| BioLineRx | 36.55M |